Women with colorectal cancer appear to have higher risk for dyspareunia, pelvic inflammatory disease, endometriosis and ...

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

See why the ovary − often reduced to its reproductive role − menopause, age and estrogen affect a woman’s health throughout ...

Knowing how ovarian cancer begins and forms could not only lead to the development of earlier screening tools, but also more ...

Women may crave and drink more alcohol during certain times of their menstrual cycle, a new study suggests. Researchers say ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with ...

LAWRENCEVILLE, N.J. - IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company with a market capitalization of $24.07 million, presented new translational data from its Phase 2 OVATION 2 ...

The SPOTLIGHT study is a Phase 1b/2a open label clinical trial evaluating a single dose of subcutaneous briquilimab in adult participants with cold urticaria (ColdU) or symptomatic dermographism ...